Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer

摘要

Figure 1. Model structure. (A) Model 1: Chemotherapy Markov model. (B) Model 2: Post-chemotherapy Markov model. The cycle length of the models were 3 weeks and 1 year for the on-chemotherapy model (model 1) and post-chemotherapy model (model 2), respectively. SN, severe neutropenia; FN, febrile neutropenia; RDI, relative dose intensity.